Increasing prevalence of stroke cases worldwide drives the demand for neurothrombectomy devices as they are essential for removing blood clots efficiently and safely. Moreover, advancements in technology, such as the development of newer devices with improved efficacy and safety profiles, further propel market growth. Additionally, rising healthcare expenditure and an aging population contribute to the expanding market opportunities for neurothrombectomy devices.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product Type, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Medtronic Plc, Stryker, Penumbra,, Johnson & Johnson, MicroVention, Inc (Terumo), Acandis, Phenox(Wallaby Medical), Vesalio, LLC, AngioDynamics,, Abbott Laboratories, Edward Lifesciences, Boston Scientific |
High cost associated with neurothrombectomy devices poses a major challenge for market growth, especially in developing economies where affordability is a concern. Furthermore, stringent regulatory requirements for product approval and the lengthy process of obtaining regulatory clearance can hinder the entry of new players in the market, limiting competition and innovation in the industry.